Louisiana files federal antitrust suit against Express Scripts and Ascent Health Services
Louisiana Attorney General Liz Murrill has sued Express Scripts, Inc. and its group purchasing affiliate Ascent Health Services LLC in federal court, alleging a conspiracy with Prime Therapeutics to fix pharmacy reimbursement rates. The complaint also alleges that manufacturer rebates were reclassified as fees and that patients were steered to Express Scripts-affiliated pharmacies.
Louisiana Attorney General Liz Murrill has filed a 66-page antitrust complaint against pharmacy benefit manager Express Scripts, Inc. and its affiliate Ascent Health Services LLC in the US District Court for the Eastern District of Louisiana, with the filing date reported as August 31, 2026. The state is seeking damages, civil penalties, attorneys' fees and an injunction under federal and Louisiana law. No damages figure has been made public.
The central allegation is that Express Scripts entered into an unlawful agreement with Prime Therapeutics, a rival pharmacy benefit manager, to coordinate the reimbursement rates and fees paid to independent pharmacies. The complaint also targets Ascent, the Express Scripts-affiliated group purchasing organisation that negotiates with drug manufacturers. The state alleges Express Scripts and Ascent used their market power to extract rebates, fees and other payments from manufacturers in exchange for formulary access. It further alleges they hid or reclassified manufacturer payments as fees rather than rebates, making it harder for health plans to verify whether negotiated savings were passed through. The complaint cites audits involving federal employee health plans as examples of alleged overcharges. It also accuses Express Scripts of using its ownership of specialty and mail-order pharmacies to steer patients away from independent pharmacies through network design, formulary decisions, coverage requirements and co-pay differentials.
The attorney general's announcement did not include a response from Express Scripts or Ascent. Neither company is recorded as having filed a response in court at the time of writing.
The Louisiana action arrived days after Florida sued Express Scripts and Prime over the same 2019 collaboration, and it moves the dispute into federal court. It also puts a spotlight on rebate aggregators — PBM-affiliated purchasing entities that the FTC scrutinised in its 2024 insulin case. Express Scripts resolved that FTC case in February 2026 with a consent order that included a commitment to reshore Ascent. Murrill's office emphasised the threat that independent pharmacy closures pose to healthcare access in rural and underserved parts of the state.
The case is at the pleading stage. Express Scripts and Ascent will be expected to answer or move to dismiss under the Federal Rules of Civil Procedure, and no hearing dates had been publicly announced. The complaint has been published on the Louisiana attorney general's website.
Cite this report
The Precedent. "Louisiana files federal antitrust suit against Express Scripts and Ascent Health Services." September 17, 2026. https://theprecedent.org/article/louisiana-files-federal-antitrust-suit-against-express-scripts-and-ascent-health
